Temephos

Overview

Temephos (Temefos) is an orally active, blood-brain barrier-permeable organophosphate insecticide and AChE inhibitor. By irreversibly inhibiting AChE to induce cholinergic overactivation, Temephos effectively blocks larval development of Aedes aegypti (yellow fever mosquito) and Aedes albopictus (Asian tiger mosquito), and is commonly used in studies related to Dengue Virus , Zika Virus and other relevant pathogens. Temephos exhibits genotoxicity and neurodevelopmental toxicity, and may also cause liver injury, reproductive system abnormalities and cholinergic poisoning symptoms in mammals. Temephos tends to accumulate in adipose tissues and aquatic organisms, and is excreted via feces after metabolism through oxidation and hydrolysis. Note that CYP -mediated metabolic detoxification may reduce the actual larvicidal efficacy of Temephos against some mosquito species. Temephos can be used in research related to dengue fever, Zika virus disease, chikungunya and dracunculiasis.

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Parasitic Infection | Products > Disease Areas > Infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Insecticide | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > Dengue Virus | Products > Signaling Pathways > Flavivirus

Product Information

• Catalog No.: HY-B1120
• CAS No.: 3383-96-8
• Molecular Formula: C16H20O6P2S3
• Molecular Weight: 466.47
• Purity: 99.35%
• Storage: Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (5.36 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source